Swine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Revenue 2024 to 2034
Swine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Revenue 2024 to 2034
The Swine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market is projected to grow from USD 1.70 Bn in 2024 to USD 5.31 Bn by 2034, at a CAGR of 12.0%. Growth is fueled by rising swine disease outbreaks, increasing pork production, and demand for effective animal health vaccines globally.
Report ID: 10356
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD 1.70 Bn
Forecast Year,
USD 5.31 Bn
CAGR, 2025 -
12.07%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Swine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Analysis
Swine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size By Modality 2024 to 2034 (USD )
| Modality | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MRI/CT/US Platforms | 0.61 | 0.68 | 0.77 | 0.86 | 0.96 | 1.08 | 1.20 | 1.36 | 1.52 | 1.70 | 1.90 |
| X-ray/Fluoroscopy | 0.31 | 0.34 | 0.39 | 0.43 | 0.49 | 0.54 | 0.61 | 0.68 | 0.76 | 0.86 | 0.96 |
| PET/SPECT | 0.27 | 0.30 | 0.34 | 0.38 | 0.42 | 0.48 | 0.54 | 0.60 | 0.67 | 0.75 | 0.84 |
| Software/AI | 0.31 | 0.35 | 0.39 | 0.43 | 0.49 | 0.55 | 0.62 | 0.69 | 0.77 | 0.87 | 0.98 |
| Other | 0.20 | 0.23 | 0.25 | 0.29 | 0.32 | 0.36 | 0.40 | 0.44 | 0.50 | 0.56 | 0.63 |
Swine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size By Application 2024 to 2034 (USD )
| Application | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oncology | 0.58 | 0.65 | 0.72 | 0.81 | 0.90 | 1.01 | 1.13 | 1.27 | 1.41 | 1.58 | 1.77 |
| Cardiology | 0.31 | 0.34 | 0.38 | 0.43 | 0.48 | 0.54 | 0.61 | 0.68 | 0.76 | 0.86 | 0.96 |
| Neurology | 0.27 | 0.31 | 0.34 | 0.39 | 0.43 | 0.49 | 0.55 | 0.62 | 0.70 | 0.78 | 0.88 |
| Orthopedics | 0.20 | 0.23 | 0.26 | 0.29 | 0.32 | 0.36 | 0.41 | 0.45 | 0.51 | 0.57 | 0.64 |
| Others | 0.34 | 0.38 | 0.43 | 0.48 | 0.54 | 0.60 | 0.67 | 0.75 | 0.84 | 0.95 | 1.06 |
Swine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size By End-User 2024 to 2034 (USD )
| End-User | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | 0.99 | 1.10 | 1.23 | 1.38 | 1.54 | 1.73 | 1.94 | 2.17 | 2.43 | 2.73 | 3.08 |
| Imaging Centers | 0.44 | 0.50 | 0.56 | 0.63 | 0.71 | 0.80 | 0.89 | 1.01 | 1.14 | 1.27 | 1.42 |
| Academic/Research | 0.20 | 0.23 | 0.26 | 0.29 | 0.32 | 0.36 | 0.40 | 0.44 | 0.49 | 0.55 | 0.61 |
| Others | 0.07 | 0.08 | 0.09 | 0.10 | 0.11 | 0.12 | 0.13 | 0.15 | 0.17 | 0.19 | 0.21 |
Swine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 0.71 | 0.80 | 0.90 | 1.01 | 1.14 | 1.27 | 1.43 | 1.60 | 1.80 | 2.01 | 2.24 |
| Europe | 0.48 | 0.53 | 0.59 | 0.66 | 0.74 | 0.83 | 0.93 | 1.04 | 1.17 | 1.31 | 1.47 |
| Asia Pacific | 0.41 | 0.46 | 0.51 | 0.57 | 0.64 | 0.72 | 0.80 | 0.90 | 1.00 | 1.13 | 1.27 |
| Latin America | 0.05 | 0.06 | 0.06 | 0.07 | 0.08 | 0.09 | 0.10 | 0.11 | 0.13 | 0.14 | 0.16 |
| Middle East & Africa | 0.05 | 0.06 | 0.06 | 0.07 | 0.08 | 0.09 | 0.10 | 0.11 | 0.13 | 0.15 | 0.16 |
Swine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market
Swine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
